Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Cellnovo
2915
Cellnovo
Health Care
Medical
Medical Devices
Cellnovo is medical technology company that has developed the first connected all-in-one diabetes management system that helps make life easier for patients.
Suggest edits
Type
B2c
Founded
2002
Raised
$74.2M
Follow us
Also headquartered in London
Blockchain
Reuters
Springwise
BBC
Revolut
DeepMind
Volkswagen
HSBC
Cambridge Analytica
Ubuntu
Companies in the same industry
Alveo Technologies
Invenshure
Observe Design
Tasso
Current Health
QSpex
Concure Oncology
da Vinci Surgery
NeoTract
RapidAI
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
€17,500,000
Post-IPO equity - 2017
NESTA (National Endowment for Science, Technology and the Arts)
€5,400,000
Venture capital - 2016
Team Size
50+
Employees
I work here
Location
London
,
United Kingdom
Headquarters
Explore London
€17,500,000
Post-IPO equity
morningstar
,
Labiotech.eu
Cellnovo Successfully Raises €17.5 Million from Healthcare Investors
€5,400,000
Venture capital
cellnovo
Press Releases | The Cellnovo Diabetes Management System
Stock markets
